mat-napo-kQrBavaF-Fk-unsplash-1

India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report

New Delhi/New York: Pfizer and New Delhi are at loggerheads over a demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world’s biggest markets, two sources told Reuters. India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects, which is a condition Pfizer has obtained in many countries where its shots have already been widely rolled out, including Britain and the United States.

WhatsApp-Image-2021-02-18-at-1.37.07-PM-1-Copy

I3T- Advanced Diagnostic Centre has successfully concluded the first drive of Free Health Camp

18th Feb 2021, Kolkata: INTERNATIONAL INSTITUTE OF INNOVATION AND TECHNOLOGY Kolkata( I3TK), a premiere research institute for implementing innovative solutions for public health in alliance with Johns Hopkins University Bloomberg school of Public Health; has successfully concluded the free Health camp drive for the community people, completely free of cost.\ in their Advanced Diagnostic Centre ( I3T -ADC)